Page last updated: 2024-10-24

cetyltrimethylammonium ion and Chagas Disease

cetyltrimethylammonium ion has been researched along with Chagas Disease in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borges, MN1
Figueroa-Villar, JD1

Other Studies

1 other study available for cetyltrimethylammonium ion and Chagas Disease

ArticleYear
NMR interaction studies of aromatic guanyl hydrazones with micelles: model for mechanism of action of cationic antibiotics.
    Biopolymers, 2001, Volume: 62, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Cations; Cell Membrane; Cetrimonium; Cetrimonium Compounds; Chagas D

2001